Israeli scientists claim coronavirus vaccine three months away
"There is a high urgency around the world to develop a vaccine for the coronavirus in humans, so we are working to expedite the development process and achieve an effective vaccine for the COVID-19 virus over the next 8-10 weeks and move to safety trials [in humans] within 90 days," said Migal CEO David Zigdon in a press conference.
"The vaccine developed by us for poultry is administered orally and the human vaccine offered by us is also expected to be administered orally."
Zigdon noted that due to the urgent global need for the vaccine, Migal is working around the clock with potential partners to help accelerate the research process in humans needed to complete the final product development and regulatory process.
"The vaccine developed by us for poultry is administered orally and the human vaccine offered by us is also expected to be administered orally."
Zigdon noted that due to the urgent global need for the vaccine, Migal is working around the clock with potential partners to help accelerate the research process in humans needed to complete the final product development and regulatory process.